Skip to main content
OpenTrials

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,990 public trials 1,836 recruiting studies
Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Completed

A Study of YM155 Plus Rituximab in Subjects With Non-Hodgkin's Lymphoma Who Have Received Prior Treatment

NCT01007292

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • Site US2778 John B. Amos Cancer Center Columbus, Georgia, United States
  • Site US55 Loyola University Hospital - Maywood Maywood, Illinois, United States
  • Site US9 Mount Sinai School of Medicine New York, United States
  • Site US2802 Mecklenburg Medical Group Charlotte, North Carolina, United States
View all 19 locations
View Trial Details
Completed

A Phase II Study of MDX-060 in Subjects With Relapsed or Refractory Hodgkin's Disease

NCT00284804

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Hodgkin Disease, +11 more
Locations
  • City of Hope, National Medical Center Duarte, California, United States
  • California Oncology of the Central Valley Fresno, California, United States
  • University of California, San Diego/Moores UCSD Cancer Center La Jolla, California, United States
  • H. Lee Moffitt Cancer & Research Institute Tampa, Florida, United States
View all 17 locations
View Trial Details
Completed

Transplant-Related Mortality in Patients Undergoing a Peripheral Blood Stem Cell Transplantation or an Umbilical Cord Blood Transplantation

NCT02188290

Conditions
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +18 more
Locations
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
  • Algemeen Ziekenhuis Sint-Jan Bruges, Belgium
  • Institut Jules Bordet Brussels, Belgium
  • Universitair Ziekenhuis Gasthuisberg Leuven, Belgium
View Trial Details
Completed

Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer

NCT00134004

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Blood Protein Disorders, +63 more
Locations
  • Blood and Marrow Transplant Program at Northside Hospital Atlanta, Georgia, United States
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
  • Hahnemann University Hospital Philadelphia, Pennsylvania, United States
View Trial Details

Related conditions